3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Leukemia, Myeloid, Acute
58
Breast Neoplasms
54
Lymphoma
52
Multiple Myeloma
49
Precursor Cell Lymphoblastic Leukemia-Lymphoma
48
Leukemia
48
Lymphoma, Non-Hodgkin
46
Melanoma
43
Lymphoma, Large B-Cell, Diffuse
41
Leukemia, Lymphocytic, Chronic, B-Cell
40
Myelodysplastic Syndromes
39
Lymphoma, Follicular
29
Burkitt Lymphoma
25
Hodgkin Disease
24
Neoplasm Metastasis
22
Recurrence
21
Neoplasms
21
Lymphoma, Mantle-Cell
20
Lymphoma, B-Cell, Marginal Zone
18
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
18
Ovarian Neoplasms
17
Carcinoma, Non-Small-Cell Lung
17
Primary Myelofibrosis
14
Neoplasms, Plasma Cell
14
Myeloproliferative Disorders
14
Lymphoma, B-Cell
14
Hematologic Neoplasms
14
Leukemia, Myelomonocytic, Chronic
13
Carcinoma, Renal Cell
13
Triple Negative Breast Neoplasms
12
Interventions
Granulocyte-Macrophage Colony-Stimulating Factor
1
Diphtheria-Tetanus Vaccine
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Xanthomatosis, Cerebrotendinous
×
Cyclophosphamide
×
Clear all
NCT03396575
2025-10-29
BRAVO
University of Florida
Phase 1
Terminated
11 enrolled